TSPAN32 suppresses chronic myeloid leukemia pathogenesis and progression by stabilizing PTEN.
Qiu Q, Sun Y, Yang L, Li Q, Feng Y, Li M, Yin Y, Zheng L, Li N, Qiu H, Cui X, He W, Wang B, Pan C, Wang Z, Huang J, Sample KM, Li Z, Hu Y.
Qiu Q, et al. Among authors: li z, li m, li n, li q.
Signal Transduct Target Ther. 2023 Mar 1;8(1):90. doi: 10.1038/s41392-022-01290-7.
Signal Transduct Target Ther. 2023.
PMID: 36854750
Free PMC article.